Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

Health, Fitness & Food

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.)

Products You May Like

Articles You May Like

RFK Jr. is Trump’s pick to lead HHS — here’s what he could do with that power
19 Early Black Friday Fitness Deals to Grab Before They Sell Out
I Tried the $7,500 a Month Gym. Is It Worth It?
Fitness Professionals Deal With Body Dysmorphia, Too. Here’s How They Heal.
CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices

Leave a Reply

Your email address will not be published. Required fields are marked *